ARCpoint Labs’ breadth of services puts owners at the forefront of diagnostic testing for numerous growing industries related to health and wellness, including transportation and logistics, construction, retail, local government, warehouses, small and medium-sized business, and more. An estimated 5.58 million small and medium-sized business operate in the United States with 44% reporting they conduct no drug testing (Sources: SBA Office of Advocacy, U.S. Census Bureau, Quest Diagnostics, National Safety Council, and Ogletree Deakins).
Drug and Alcohol Screening
The rise in drug testing demand is anticipated to continue, reaching $4.01 billion by 2030 with Key Market Drivers including OSHA compliance, worker’s comp exposure, DOT and HHS rule changes, and the fentanyl crisis (Sources: Grand View Research (2025); Quest Diagnostics Drug Testing Index (2025); DISA Global Solutions (2025); U.S. DOT Federal Register (2025)). ARCpoint Labs franchisees have immense opportunity to grow in this space, often while capitalizing on residual income.